Keywords
Streptococcus agalactiae
Estreptococo del grupo B
Sepsis neonatal Colonization
Streptococcus agalactiae
Group B Streptococcus
Neonatal sepsis
How to Cite
Abstract
To determine the prevalence of maternal vaginal-rectal colonization of group B streptococcus (GBS) in pregnant women who are between gestational weeks 35th and 37th. Design: prospective prevalence descriptive study. Methods: obstetric patients in a private clinic in Bogota who attended between Spril st and September 30th 2008 were included. Screening of group B strep was performed through vaginal and/or rectal cultures according to groups. In the first group vaginal swabs were taken and in the second one vaginal rectal swabs were done. Data from patients whose cultures were positive were identified and anatomical site was identified. Finally, prevalences were determined as well as incidence of early newborn infection within the sample of the study. Results: a sample of 1000 pregnant women was included. 72 women were excluded for not complying with inclusion criteria. Mean age was 27.6 years (SD: ± 1.1; range 35 - 41), mean parity 1.8 (SD: ± 1.0; range 1 - 10). There were no differences between maternal age, parity and colonization with GBS. From screened women only with vaginal cultures, 1.7% presented with positive cultures for GBS. Women screened with vaginal rectal a total of 16.4% presented as positive. Every woman identified as positive was medicated with prophylaxis and no early neonatal infections were detected. Conclusions: prevalence of vaginal-rectal colonization with GBS between gestational weeks 35th and 37th was of 16.4%. Screening through vaginal swabs identified a mean of 1.7%.There were no identified cases of early neonatal infection.
References
Mandell G., Bennett J., Dolin R. Principles and practice of Infectious Diseases. Fourth edition. New York. Ed.Churchill Livingstone. 1995; 2:1835 -1843.
Romero R., Chaiworapongsa T. Preterm labor, Intrauterine Infection, and the Fetal Inflammatory Response Syndrome. NeoReviews. 2002;3(5): e73- e85. https://doi.org/10.1542/neo.3-5-e73
Tumbaga P., Philip A. Perinatal Group B Streptococcal Infections and the New Guidelines: An Update. NeoReviews. 2006; l7(10): e524 - e529. https://doi.org/10.1542/neo.7-10-e524
Larsen J., Sever J. Group B Streptococcus and pregnancy: a review. American Journal of Obstetrics and Gynecology. 2008;198(4):440-448. https://doi.org/10.1016/j.ajog.2007.11.030
Sharg S., Gorwitz R., Fultz-Butts K., Schuchat A. Prevention of perinatal Group Streptococcal Disease Revised Guidelines from CDC. MMWR. 2002;51(RR 11):1 -22.
Center for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR. 1996; 707-18
Benitz W. Perinatal treatment to prevent early onset group B streptococcal sepsis. Semin Neonatol. 2002;7: 301-314. https://doi.org/10.1053/siny.2002.0117
Zangwill KM., Schuchat A., Wenger JD. Group B streptococcal disease in the United States, 1990: Report from a multistate active surveillance system. MMWR. 1992; 41 (SS-6 ): 25-32.
Schrag S, Zell E. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. The New England Journal of Medicine. 2002; 347(4): 233-239. https://doi.org/10.1056/NEJMoa020205
CDC. Laboratory practices for prenatal group B streptococcal screening and reporting - Connecticut, Georgia, and Minnesota. 1997-1998. MMWR. 1999; 48: 426-8.
Escobar GJ., Li D., Armstrong MA., Gardner M., Folk B., Verdi J. et al. Neonatal sepsis workups in infants mayor a 2000 grams at birth: a population-based study. Pediatrics. 2000; 106: 256-63. https://doi.org/10.1542/peds.106.2.256
Illuzzi JL., Bracken MB. Duration of intrapartum prophylaxis for neonatal group B streptococcal disease: a systematic review. Obstet Gynecol. 2006 Nov; 108(5):1254 - 65. https://doi.org/10.1097/01.AOG.0000241539.86451.11
Colombo D., Lew J., Pedersen C., Johnson J., Fan-Havard P. Optimal timing of ampicillin administration to pregnant women for establishing bactericidal levels in the prophylaxis of group B Streptococcus. American Journal of Obstetrics and Gynecology. 2006; 194, 466-70. 1 https://doi.org/10.1016/j.ajog.2005.07.098
Alvarez JR., Williams S., Ganesh V., Apuzzio J. Duration of antimicrobial prophylaxis for group B streptococcal in patients with prterm premature rupture of membranes who are not in labor. American Journal of Obtetrics and Ginecology. 2007 ) 390): e1 -e4. https://doi.org/10.1016/j.ajog.2007.06.047
Cheng P., Chueh H. Risk factors for recurrence of group B streptococcus colonization in subsequent pregnancy. American College of Obstetricians and Gynecologists. 2008;111(3):704-709. https://doi.org/10.1097/AOG.0b013e318163cd6b
Benitz WE. Perinatal treatment to prevent earlyonset group B streptococcal sepsis. Semin Neonatol. 2000; 7 : 301- 314. https://doi.org/10.1053/siny.2002.0117
Monique A., Louis A., Kolle A., Albert A., Kimpen J., Gerards L. Neonatal group B streptococcal infection: incidence and strategies for prevention in Europa. The Pediatrics Infectious Disease Journal. 2004; 23 2): 172 -73. https://doi.org/10.1097/01.inf.0000111212.94913.5f
Zusman AS., Baltimore RS., Fonseca SN.. Prevalence of maternal group B streptococcal colonization and related risk factors in a Brazilian population. Braz J Infect Dis. 2006 Aug;10(4):242-6 https://doi.org/10.1590/S1413-86702006000400005
Di Bartolomeo S., Gentile M., Priore G., Valle S., Di Bella A. Streptococcus agalactiae en embarazadas. Prevalencia en el Hospital Nacional Alejandro Posadas. Rev. Argent. Microbiol. 2995; 37 (3):142-144
Diaz RT., Nieves B., Vegas L. Colonización vaginoanorrectal por Streptococcus del grupo B en mujeres embarazadas con complicaciones ginecoobstétricas. Rev. Soc. Ven. Microbiol. 2002;22(1):12-17
Reyna Figueroa J., Ortiz Ibarra FJ., Esteves Jaramillo A., Casanova Román G. Colonización materna por Streptococcus del grupo B en México: estimación de la prevalencia basada en la revisión bibliográfica. Ginecol Obstet Mex. 2007;75(7):399-403
Guzman A., Abarzúa F., Belmar C., García P. Resultado de la aplicación del protocolo basado en screening para la búsqueda de Streptococcus agalatiae en el tercer trimestre del embarazo. Posible impacto sobre la sepsis neonatal precoz por este agente. Revista Chilena de Infectología. 2001. Vol 18 3; https://doi.org/10.4067/S0716-10182001000300005
Manotas RJ., Baquero D., Agudelo N., Zapata C. Frecuencia de aislamiento de Streptococcus agalactiae en un grupo de embarazadas y sus productos. IATREIA. 1989; 2:111-13.
Restrepo A., Serna L., Vanegas C., Sarria C., Durango H., Zapata C. et al. Prevalencia del Streptococcus agalactiae en gestantes con factores de riesgo y sus recién nacidos. Hospital Universitario San Vicente de Paúl. Infectio, 2003;7:147 -52.
Abril IF., Fama M., Ospina B. Reevaluación del estado de colonización por Estreptococo del grupo B en madres e hijos al momento del parto. Rev Ces Medicina. 1999; 13:44 - 46.
González CP., Gonzalez JE., Ovalle O., Mesa MP., León A., Sarmiento A. Prevalencia de Estreptococo B hemolítico en mujeres embarazadas de alto riesgo en el Hospital Simón Bolivar de Bogotá. UCIN. 2001; Vol 2.
Valdés E., Pastene C., Morales A., Gutiérrez B., Canales A., Martínez P., et al. Prevalencia de colonización por Streptococcus agalactiae (grupo B) durante el embarazo pesquisado en medio de cultivo selectivo. Rev Chilena Obstetricia y Ginecología. 2004; 69 (2): 132 -135. https://doi.org/10.4067/S0717-75262004000200008
Tamariz J., Obregón M., Jara J., Díaz J., Jefferson L., Guerra H. Colonización vaginal y anorectal por Streptococcus Agalactiae en gestantes de los hospitales nacionales Cayetano Heredia y Arzobispo Loayza. Rev Med Her. 2004;15(3): 144 -150. https://doi.org/10.20453/rmh.v15i3.783
Centers for Disease Control and Prevention (CDC). Trends in perinatal group B streptococcal disease - United States, 2000-2006. MMWR. 2009; 58(5):109-12
Cortés H. Prevención de la infección neonatal por estreptococo del grupo, ¿Es necesaria en nuestro medio? Revista Colombiana de Obstetricia y Ginecología. 2005;56(3):231-238. https://doi.org/10.18597/rcog.531
Crespo M., Vélez J. Importancia clínica del Streptococcus agalactiae como causante de infección. Colombia médica. 1996; 27: 53-58.
Cifuentes Y., Ruiz A., Leal A. Perfil microbiológico de aislamientos en unidades neonatales en un hospital de tercer nivel de Bogotá, Colombia. Rev. Salud Pública. 2005; 7 )2); 191 -200 https://doi.org/10.1590/S0124-00642005000200007
Towers CV., Bringgs GC.. Antepartum use of antibiotics and early- onset neonatal sepsis: The next 4 years. Am J Obstec Gynecol. 2002; 187 2 ): 495-500. https://doi.org/10.1067/mob.2002.124277
Instituto Nacional de Salud Colombia. Disponible en: htpp: www. ins.gov.co. Mortalidad perinatal.